Chronos Therapeutics (AgeTech UK) ^Biomed

Targetting neurological, neurodegenerative disease such as ALS and MS. Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases. The team utilises a network of industry-leading contract research organisations to develop NCE’s and repurpose existing launched drugs. Chronos also has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, Chronoscreen.